GNS Healthcare to Present Results on Prediction of Disease Progression Using AI in NASH Patients at The International Liver Congress™

CAMBRIDGE, Mass.– April 13, 2018– GNS Healthcare (GNS), a leading precision medicine company, will present results from a recent study on Friday, April 13th at the International Liver Congress™ 2018 in Paris. The analysis focused on the progression of Nonalcoholic Steatohepatitis (NASH), a type of advanced liver disease. Specifically, the objective was to build predictive models […]